Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients

NCT02401243 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
253
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi